Search

Now showing items 1-10 of 15

Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxiainduced mitochondrial mutagenesis in inflammatory arthritis

O'SULLIVAN, JACINTHA (2011)

Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis

O'SULLIVAN, JACINTHA (2012)

A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia.

REYNOLDS, JOHN; O'SULLIVAN, JACINTHA; RAVI, NARAYANASAMY (2015)

Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer

O'SULLIVAN, JACINTHA (2011)

Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a -/- mutants

O'SULLIVAN, JACINTHA (2011)

A prospective investigation of predictive and modifiable risk factors for breast cancer in unaffected BRCA1 and BRCA2 gene carriers

O'SULLIVAN, JACINTHA (2013)

Decreased Mitochondrial DNA Mutagenesis in Human Colorectal Cancer

O'SULLIVAN, JACINTHA (2012)

Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer

O'SULLIVAN, JACINTHA (2016)

COX-Derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention

REYNOLDS, JOHN; O'SULLIVAN, JACINTHA; CATHCART, MARY CLARE; PIDGEON, GRAHAM; O'BYRNE, KEN (Elsevier, 2012)

Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment.

O'SULLIVAN, JACINTHA (2012)

Browse

All of TARA

This Academic/Research Unit

Discover

Author

Subject

Date Issued

Sponsor

Search

Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxiainduced mitochondrial mutagenesis in inflammatory arthritis

Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis

A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia.

Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer

Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a -/- mutants

A prospective investigation of predictive and modifiable risk factors for breast cancer in unaffected BRCA1 and BRCA2 gene carriers

Decreased Mitochondrial DNA Mutagenesis in Human Colorectal Cancer

Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer

COX-Derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention

Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment.

Browse

All of TARA

This Academic/Research Unit

Discover

Author

Subject

Date Issued

Sponsor

Search

Advanced Search

Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxiainduced mitochondrial mutagenesis in inflammatory arthritis

Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis

A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia.

Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer

Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a -/- mutants

A prospective investigation of predictive and modifiable risk factors for breast cancer in unaffected BRCA1 and BRCA2 gene carriers

Decreased Mitochondrial DNA Mutagenesis in Human Colorectal Cancer

Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer

COX-Derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention

Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment.